Liver Fibrosis Leader

Dr. Stephen J. Sims was the first primary care provider in California to treat liver fibrosis with the first available medication, Rezdiffra. We are also one of the first primary care offices in the San Francisco Bay Area to provide Fibroscan ultrasound testing, recommended by all major guidelines for those with fatty liver or the risk factors listed below, and a FIB-4 score over 1.3 *.

Liver steatosis (fatty liver) caused by excess fats accumulating in liver cells, even without any alcohol is a serious disease which can worsen blood sugar, blood pressure and artery inflammation causing heart attacks and strokes, and lead to many cancers and even cirrhosis often requiring a liver transplant, is present in 30% of the general population, 70 to 80% of those with diabetes and obesity and 35% of South Asians.

Risk factors for liver fibrosis are obesity (BMI 30+), diabetes, prediabetes, insulin resistance, high blood pressure, alcohol use, abnormal cholesterol or triglycerides, high ALT or AST lab result.

To find out whether you might have fatty liver or liver fibrosis calculate your FIB-4 score by enter your standard blood test ALT, AST, platelet count and age in a calculator below *. If your FIB-4 score is 1.3+ then guidelines recommend the definitive Fibroscan liver ultrasound, conveniently provided in Dr. Sims' office.

The Fibroscan is fully reimbursible (commercial insurance) and covered by Medicare subject to deductible and non-invasive (harmless sound waves lightly tapping on the right side of your chest for 7 to 10 minutes). 

* Check your FIB-4 score here https://www.mdcalc.com/calc/2200/fibrosis-4-fib-4-index-liver-fibrosis.

Request a Consultation